Forward Management LLC raised its stake in shares of Varian Medical Systems, Inc. (NYSE:VAR) by 9.7% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 3,509 shares of the medical equipment provider’s stock after buying an additional 311 shares during the period. Forward Management LLC’s holdings in Varian Medical Systems were worth $362,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. Kovitz Investment Group Partners LLC acquired a new stake in Varian Medical Systems during the second quarter valued at $1,295,000. Pictet Asset Management Ltd. boosted its stake in Varian Medical Systems by 2.2% in the second quarter. Pictet Asset Management Ltd. now owns 915,887 shares of the medical equipment provider’s stock valued at $90,691,000 after buying an additional 19,361 shares in the last quarter. JLB & Associates Inc. acquired a new stake in Varian Medical Systems during the second quarter valued at $7,803,000. Eagle Ridge Investment Management boosted its stake in Varian Medical Systems by 3.2% in the second quarter. Eagle Ridge Investment Management now owns 62,364 shares of the medical equipment provider’s stock valued at $6,435,000 after buying an additional 1,922 shares in the last quarter. Finally, Candriam Luxembourg S.C.A. boosted its stake in Varian Medical Systems by 45.1% in the second quarter. Candriam Luxembourg S.C.A. now owns 14,866 shares of the medical equipment provider’s stock valued at $1,534,000 after buying an additional 4,621 shares in the last quarter. 99.27% of the stock is owned by institutional investors.

Varian Medical Systems, Inc. (VAR) opened at 97.74 on Friday. The company has a 50-day moving average price of $101.70 and a 200 day moving average price of $93.39. The company has a market capitalization of $8.97 billion, a PE ratio of 32.17 and a beta of 0.61. Varian Medical Systems, Inc. has a 12 month low of $75.20 and a 12 month high of $107.08.

Varian Medical Systems (NYSE:VAR) last released its quarterly earnings results on Wednesday, July 26th. The medical equipment provider reported $1.04 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.95 by $0.09. The business had revenue of $662.40 million during the quarter, compared to the consensus estimate of $663.86 million. Varian Medical Systems had a return on equity of 24.70% and a net margin of 9.50%. The firm’s quarterly revenue was up 3.0% on a year-over-year basis. During the same period in the previous year, the company posted $1.00 EPS. On average, equities research analysts forecast that Varian Medical Systems, Inc. will post $3.94 EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “Forward Management LLC Boosts Position in Varian Medical Systems, Inc. (NYSE:VAR)” was first posted by Watch List News and is owned by of Watch List News. If you are reading this story on another domain, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The original version of this story can be read at https://www.watchlistnews.com/forward-management-llc-boosts-position-in-varian-medical-systems-inc-nysevar/1477443.html.

Several research firms have recently weighed in on VAR. BidaskClub cut Varian Medical Systems from a “hold” rating to a “sell” rating in a research report on Thursday, August 3rd. Robert W. Baird reissued a “neutral” rating and issued a $99.00 price objective (up from $89.00) on shares of Varian Medical Systems in a research report on Friday, July 14th. Zacks Investment Research cut Varian Medical Systems from a “buy” rating to a “hold” rating in a research report on Thursday, July 13th. Aegis reissued a “hold” rating and issued a $91.00 price objective on shares of Varian Medical Systems in a research report on Wednesday, May 17th. Finally, Goldman Sachs Group, Inc. (The) began coverage on Varian Medical Systems in a research report on Tuesday, May 16th. They issued a “neutral” rating and a $92.00 price objective for the company. Three research analysts have rated the stock with a sell rating, six have given a hold rating and three have given a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average price target of $96.28.

In related news, SVP John W. Kuo sold 19,819 shares of the business’s stock in a transaction on Wednesday, May 31st. The stock was sold at an average price of $99.67, for a total value of $1,975,359.73. Following the completion of the sale, the senior vice president now directly owns 47,180 shares in the company, valued at approximately $4,702,430.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Timothy E. Guertin sold 16,000 shares of the business’s stock in a transaction on Friday, June 9th. The shares were sold at an average price of $103.22, for a total value of $1,651,520.00. Following the completion of the sale, the director now owns 2,161 shares of the company’s stock, valued at $223,058.42. The disclosure for this sale can be found here. Insiders sold a total of 158,284 shares of company stock valued at $16,022,132 over the last 90 days. 0.91% of the stock is currently owned by corporate insiders.

Varian Medical Systems Company Profile

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Want to see what other hedge funds are holding VAR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Varian Medical Systems, Inc. (NYSE:VAR).

Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.